Showing results (511-520 of 1,011) with videos related to

Sort By:
Pageof 102
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Blood|April 1, 1987
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin)M W Mosesson, J P DiOrio, M F Müller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populationsF Bernardi, P Arcieri, R M Bertina, et al.
Anaesthesia, Critical Care & Pain Medicine|October 27, 2018
Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR)A Godier, D Garrigue, D Lasne, et al.
Bone Marrow Transplantation|September 18, 2003
Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndromeS Dimicoli, D Bensoussan, V Latger-Cannard, et al.
Thrombosis Journal|September 14, 2020
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratoryM Hardy, T Lecompte, J Douxfils, et al.
Thrombosis Research|January 13, 2000
The heparin management test: a new device for monitoring anticoagulation during coronary interventionG Helft, P Bartolomeo, A G Zaman, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Lupus|April 12, 2015
Impairment of quality of life in patients with antiphospholipid syndromeS Zuily, A-C Rat, V Regnault, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Pageof 102